Assess whether pediatric studies are necessary or waivable (5baef5)

Situation

Pediatric-plan strategist in a company with a CMC site change mid-review has one working extract — CMC comparability package for a site change — after an inspector asking for batch records you cannot produce this week. If CMC comparability package for a site change cannot support pediatric studies are necessary, the honest Pharma & Life Sciences output is hold.

Decision

Pediatric-plan strategist in a company with a CMC site change mid-review must choose Pediatric studies are necessary / Waivable using CMC comparability package for a site change after an inspector asking for batch records you cannot produce this week.

Hypotheses to test

• CMC comparability package for a site change reads as Pediatric studies are necessary once an inspector asking for batch records you cannot produce this week is lined up to the same Pharma & Life Sciences population.
• CMC comparability package for a site change is closer to Waivable after an inspector asking for batch records you cannot produce this week; Pediatric studies are necessary would over-claim this CMC and Development Pathways extract.
• A dual reading is still live in CMC comparability package for a site change for pediatric-plan strategist in a company with a CMC site change mid-review.
• CMC comparability package for a site change is missing the fact pediatric-plan strategist needs after an inspector asking for batch records you cannot produce this week; stop this Pharma & Life Sciences close.

Analysis required

• Trace CMC, labeling, or pharmacovigilance facts in CMC comparability package for a site change after an inspector asking for batch records you cannot produce this week.
• Separate an isolated adverse event from a systemic quality issue.
• Test a protocol deviation versus a safety signal versus a filing gap on pediatric studies are necessary.
• For this Pharma & Life Sciences CMC and Development Pathways file, read CMC comparability package for a site change against an inspector asking for batch records you cannot produce this week and write the one fact that would move pediatric studies are necessary for pediatric-plan strategist.

Recommendation

Choose Pediatric studies are necessary / Waivable on this Pharma & Life Sciences / CMC and Development Pathways packet (CMC comparability package for a site change after an inspector asking for batch records you cannot produce this week). The follow-on CMC and Development Pathways action is what pediatric-plan strategist does next: implement the option, assign an owner, and log the missing fact.